Adjuvant therapy in hepatocellular carcinoma: the IMbrave050 trial. Shin H, Lee JH. Lancet 2024;404:654-655.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shin H, Lee JH. Adjuvant therapy in hepatocellular carcinoma: the IMbrave050 trial. Lancet 2024;404:654-655.
PMID: 39153810